Methods and apparatus to increase secretion of endogenous naturetic hormones
View Patent ↗A method and apparatus for treatment of heart failure by increasing secretion of endogenous naturetic hormones ANP and BNP such as by stimulation of the heart atria. Heart pacing is done at an atrial contraction rate that is increased and can be higher than the ventricular contraction rate. Pacing may include mechanical distension of the right atrial appendage. An implantable device is used to periodically cyclically stretch the walls of the appendage with an implanted balloon.
1. A method for pacing a heart of a patient suffering from at least one of hypertension, and excessive retention of fluid and sodium, the method comprising:
during a first pacing period synchronously pacing at least one atria and at least one ventricle of the patient's heart;
during a second pacing period,
synchronously pacing the at least one ventricle of the patient's heart at a ventricular pacing rate, and
producing extra contractions of the at least one atria by asynchronously pacing the at least one atria of the patient's heart at an atrial pacing rate that exceeds the ventricular pacing rate,
wherein the produced extra contractions stress a wall of the at least one atria beyond a natural stress condition, such that the stressed wall secretes a hormone at an elevated secretion level above a secretion level occurring while a natural atrial rate and a natural ventricular rate are equal; and
achieving a beneficial therapeutic effect in the patient by the elevated level of the secreted hormone, wherein the beneficial therapeutic effect includes at least one of: limiting a degree of vasoconstriction, limiting a degree of sodium retention, increasing urine output, inhibiting a renin-angiotensin system, inhibiting endothelin secretion, inhibiting systemic and renal sympathetic activity, and counteracting effects of at least one of norepinephrine, endothelin, and angiotensin II.
2. The method of claim 1 , further including blocking electric conduction from the atrium to the ventricle of the patient's heart during the second pacing period.
3. The method of claim 1 , further including sensing a sinus rhythm of the patient's heart and selectively synchronizing the ventricular pacing rate with the sinus rhythm.
4. The method of claim 1 , wherein the first pacing period is of a longer duration than the second pacing period.
5. The method of claim 1 , wherein the secreted hormone is at least one of an atrial natriuretic peptide (ANP) and a brain natriuretic peptide (BNP).
6. The method of claim 1 , wherein the beneficial therapeutic effect includes a treatment of heart failure.
7. The method of claim 1 , wherein the pacing during the first pacing period is artificially induced by a pacing device.
8. The method of claim 1 , further comprising repeatedly alternating the first pacing period and the second pacing period to pace the patient's heart.
9. The method of claim 1 , wherein each alternating second pacing period has a duration of at least ten minutes.
10. A method for treating a patient suffering from at least one of hypertension, and excessive retention of fluid and sodium, the method comprising:
during a first pacing period synchronously pacing at least one atria and at least one ventricle of a heart of the patient;
during a second pacing period,
pacing the patient's heart to cyclically
contract the at least one atria,
stress a wall of the at least one atria, and
restore the wall of the at least one atria to a substantially pre-stressed condition;
such that the stressed wall secretes a hormone at an elevated level above a natural secretion level occurring naturally when the patient's heart is not paced; and
achieving a beneficial therapeutic effect in the patient by the hormone secreted at the elevated level, wherein the beneficial therapeutic effect includes at least one of: limiting a degree of vasoconstriction, limiting a degree of sodium retention, increasing urine output, inhibiting a renin-angiotensin system, inhibiting endothelin secretion, inhibiting systemic and renal sympathetic activity, and counteracting effects of at least one of norepinephrine, endothelin, and angiotensin II.
11. The method of claim 10 , wherein pacing the patient's heart during the second pacing period comprises pacing the at least one ventricle at a ventricular pacing rate and pacing the at least one atria of the patient's heart at an atrial pacing rate that exceeds the ventricular pacing rate.
12. The method of claim 10 , wherein pacing the patient's heart during the second pacing period to cyclically stress the wall of the at least one atria comprises pacing the at least one atria at an accelerated rate that causes extra contractions of the at least one atria.
13. The method of claim 10 , wherein pacing the patient's heart during the second pacing period to cyclically stress the wall of the at least one atria comprises pacing an atrium of the patient's heart to contract atrial muscle at a cyclical rate faster than a ventricular contraction rate of the patient's heart.
14. The method of claim 10 , wherein the pacing during the first pacing period is artificially induced by a pacing device.
15. The method of claim 10 , further comprising repeatedly alternating the first pacing period and the second pacing period to pace the patient's heart.
16. The method of claim 15 , wherein each alternating second pacing period has a duration of at least ten minutes.
17. A method for treating a patient suffering from at least one of hypertension, and excessive retention of fluid and sodium, the method comprising:
during a first pacing period synchronously pacing at least one atria and at least one ventricle of a heart of the patient;
during a second pacing period,
producing extra contractions of the at least one atria by pacing the at least one atria at an atrial contraction rate faster than a ventricular contraction rate,
wherein the produced extra contractions stress at least one wall of the at least one atria of the patient's heart so as to induce a tissue in the at least one stressed wall to secrete greater amounts of a hormone as compared to a secretion amount of the hormone occurring when no pacing is applied to the patient's heart; and
achieving a beneficial therapeutic effect to the patient due to the secretion of the greater amounts of the hormone, wherein the beneficial therapeutic effect includes at least one of: limiting a degree of vasoconstriction, limiting a degree of sodium retention, increasing urine output, inhibiting a renin-angiotensin system, inhibiting endothelin secretion, inhibiting systemic and renal sympathetic activity, and counteracting effects of at least one of: norepinephrine, endothelin, and angiotensin II.
18. The method of claim 17 , wherein producing the extra contractions of the at least one atria during the second pacing period comprises pacing an atrium at an atrial pacing rate that is faster than the ventricular contraction rate.
19. The method of claim 17 , wherein the second pacing period comprises pacing a ventricle of the patient's heart at a ventricular pacing rate slower than the atrial contraction rate.
20. The method of claim 17 , further comprising atrioventricular blocking of atrial electric impulses from reaching a ventricle of the patient's heart during the second pacing period.
21. The method of claim 17 , further comprising atrioventricular blocking of atrial depolarization from reaching a ventricle of the patient's heart and causing ventricular depolarization during the second pacing period.
22. The method of claim 17 , wherein the pacing during the first pacing period is artificially induced by a pacing device.
23. The method of claim 17 , further comprising repeatedly alternating the first pacing period and the second pacing period to pace the patient's heart.
24. The method of claim 17 , wherein each alternating second pacing period has a duration of at least ten minutes.